CLOBETASOL PROPIONATE (EMOLLIENT) Drug Patent Profile
✉ Email this page to a colleague
When do Clobetasol Propionate (emollient) patents expire, and what generic alternatives are available?
Clobetasol Propionate (emollient) is a drug marketed by Ani Pharms, Fougera Pharms, Pai Holdings Pharm, and Taro. and is included in four NDAs.
The generic ingredient in CLOBETASOL PROPIONATE (EMOLLIENT) is clobetasol propionate. There are fourteen drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the clobetasol propionate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Clobetasol Propionate (emollient)
A generic version of CLOBETASOL PROPIONATE (EMOLLIENT) was approved as clobetasol propionate by COSETTE on February 16th, 1994.
Summary for CLOBETASOL PROPIONATE (EMOLLIENT)
US Patents: | 0 |
Applicants: | 4 |
NDAs: | 4 |
Finished Product Suppliers / Packagers: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 80 |
Patent Applications: | 4,476 |
Formulation / Manufacturing: | see details |
DailyMed Link: | CLOBETASOL PROPIONATE (EMOLLIENT) at DailyMed |
Pharmacology for CLOBETASOL PROPIONATE (EMOLLIENT)
Drug Class | Corticosteroid |
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |